University of Washington, Seattle, USA.
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S216-9. doi: 10.1086/653522.
Outpatient care, including outpatient parenteral antimicrobial therapy (OPAT), is increasingly seen by both clinicians and insurers as a safe, effective, and economical adjunct or alternative to hospitalization. Despite this, perhaps the least understood reimbursement and regulatory policies for health care services are those that apply to OPAT. We present a brief review and update of current rules and regulations relating to OPAT, with emphasis on areas of special interest to physicians serving as medical directors of home or ambulatory infusion programs or providing OPAT as an extension of their office practices.
门诊护理，包括门诊肠外抗菌治疗（OPAT），越来越受到临床医生和保险公司的重视，被视为一种安全、有效且经济的住院替代或辅助治疗方法。尽管如此，对于医疗服务而言，OPAT 的报销和监管政策或许是最不被理解的。我们简要回顾和更新了与 OPAT 相关的现行规则和法规，重点关注作为家庭或门诊输液计划的医疗主任或作为其办公室实践延伸提供 OPAT 的医生特别关注的领域。
